- Unveiling expression patterns, mechanisms, and therapeutic o... 2025-01-18
- Identification of patients with advanced pancreatic cancer w... 2025-01-18
- Metastatic lymph node distribution and pathology correlation... 2025-01-18
- Prognosis in stage II colon cancer: Expanding the horizons o... 2025-01-18
- Innovative applications and research progress of hepatic art... 2025-01-18
World Journal of Gastrointestinal Oncology (WJGO, World J Gastrointest Oncol) is a high-quality, online, open-access, single-blind peer-reviewed journal published by the Baishideng Publishing Group. WJGO accepts both solicited and unsolicited manuscripts. Articles published in WJGO are high-quality, clinical and basic, influential research articles by established academic authors as well as new researchers. The paramount objective of WJGO is to showcase and promote distinguished research in the field of gastrointestinal oncology, to help advance development of this field. The types of articles published in the WJGO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. Submit here >>
- Monjur Ahmed, AGAF, FACG, FACP, FASGE, FRCP, MD, MRCP, Doctor, Editor-in-Chief, Full Professor, (E-mail: monjur.ahmed@jefferson.edu) Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA 19107, United States
The 2024 edition of Journal Citation Reports® cites the 2023 journal impact factor (JIF) for WJGO as 2.5; JIF without journal self cites: 2.5; 5-year JIF: 2.8; JIF Rank: 72/143 in gastroenterology and hepatology; JIF Quartile: Q3; and 5-year JIF Quartile: Q2.
The WJGO’s CiteScore for 2023 is 4.2 and Scopus CiteScore rank 2023: Gastroenterology is 80/167; Oncology is 196/404.